Abstract:
Currently, infections produced by the gram-positive bacteria S. aureus represent a significant healthcare burden
throughout the world. This is attributed to the ability of this bacterium to develop antibiotic resistance
and efficiently evade human immune response. Therefore, research effort of many scientific laboratories
worldwide is directed toward characterization of the genetic organization and molecular mechanisms responsible
for S. aureus pathogenesis. This report is aimed to describe the growing body of evidence related to our
understanding of the genetic organization and molecular interactions of the S. aureus leukocidins with the
human cells that play an important role in bacterial pathogenesis, and represent a significant healthcare burden.
Understanding of the genetic organization linked with additional mechanisms responsible for the realization
of toxic potential, can help us to develop a better personalized approach for therapy against S. aureus infections.
Thus, improved understanding of the molecular interactions between S. aureus leucocidins, and cell
surface receptors may lead to the development of the alternative anti-microbial agents, that either independently
or in combination with the current antibiotic treatment regimens will be used as an effective treatment
strategy in clinic.
